These findings are also consistent with work published by Benter and colleagues, who showed that A(1–7) administration to a rat model of streptozotocin-induced diabetes reduced activity of renal NADPH oxidase and decreased expression of NOX-4 [33]. This evidence concerns the gene FMO5 and diabetes mellitus.